Sunday, May 22, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

FBI Seeks Tamiflu Supplier for Pandemic Flu Preparedness Program

by Global Biodefense Staff
July 12, 2018
Tamiflu Antiviral MCM - Pandemic Preparedness

The Federal Bureau of Investigation (FBI) is seeking suppliers for anti-viral therapeutic Tamiflu to support is Pandemic Flu Preparedness Program stockpile.

The FBI needs approximately 3,300 does of Tamiflu each year and in order to meet its stockpile requirements, which must be rotated on continuous use and expiring medications. The product is oseltamivir (Tamiflu) 75mg capsules in containers of 10 caps per bottle.

The medicine shall have been demonstrated by the United States Centers for Disease Control (CDC) to be effective in treating Influenza A, H1N1 Influenza and H5N1 Avian Influenza.

The FBI anticipates awarding a Firm Fixed-Price Blanket Purchase Agreement for a performance period of one base year and four option years.

Delivery shall be FOB-Destination and delivery locations will be designated for each order to one of the following four locations; Washington D.C.; Fredericksburg, VA; Dallas, TX; or Los Angeles, CA.

Further details are available via FBO.gov Solicitation Number: RFI-HCPU-18-317.

Tags: InfluenzaRFIStrategic National Stockpile

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC